[Skip to Navigation]
Views 1,061
Citations 0
Challenges in Clinical Electrocardiography
November 26, 2018

Electrocardiographic Harbingers of Ventricular Tachycardia Arrest—A Moment of Pause

Author Affiliations
  • 1Department of Medicine, University of California, San Francisco
  • 2Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • 3Division of Cardiology, Department of Medicine, University of California, San Francisco
  • 4Division of Cardiology, Department of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California
JAMA Intern Med. 2019;179(2):249-251. doi:10.1001/jamainternmed.2018.6220

A woman in her 40s presented to the emergency department (ED) with nausea and vomiting of 6 days’ duration associated with watery diarrhea and anorexia. She denied fever or abdominal pain. Two days prior to presentation, her physician had administered 4 mg of ondansetron intramuscularly and prescribed 4-mg ondansetron tablets, of which she took 3 over the course of 2 days.

In the ED, her vital signs and physical examination findings were unremarkable. Laboratory testing revealed a serum potassium level of 3.1 mEq/L and a serum magnesium level of 1.9 mg/dL. Her initial electrocardiogram (ECG) revealed sinus rhythm with ventricular ectopy (Figure 1). The automated calculation of the QTc was 626 milliseconds (ms). Given frequent runs of nonsustained polymorphic ventricular tachycardia (NSVT) seen on telemetry, the ED physician administered a bolus intravenous (IV) dose of 150 mg of amiodarone, in addition to 2 g of IV magnesium sulfate (Mg++) and 20 mEq of IV potassium sulfate (K+). A subsequent ECG recorded 4 hours later is shown in Figure 2A.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words